These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14998946

  • 1. Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.
    Vanky E, Salvesen KA, Carlsen SM.
    Hum Reprod; 2004 Mar; 19(3):529-33. PubMed ID: 14998946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
    Carlsen SM, Vanky E, Fleming R.
    Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
    [Abstract] [Full Text] [Related]

  • 4. Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.
    Vanky E, Kjøtrød SB, Maesel A, Bjerve KS, Carlsen SM.
    Fertil Steril; 2004 Feb; 81(2):459-62. PubMed ID: 14967392
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 7. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 8. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [Abstract] [Full Text] [Related]

  • 9. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
    Carlsen SM, Kjøtrød S, Vanky E, Romundstad P.
    Acta Obstet Gynecol Scand; 2007 Jan; 86(2):145-50. PubMed ID: 17364275
    [Abstract] [Full Text] [Related]

  • 10. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB, Sunde A, von Düring V, Carlsen SM.
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [Abstract] [Full Text] [Related]

  • 11. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 07; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 14. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.
    Metabolism; 2007 Jan 01; 56(1):129-34. PubMed ID: 17161235
    [Abstract] [Full Text] [Related]

  • 15. The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome.
    Ertunc D, Tok EC, Aktas A, Erdal EM, Dilek S.
    Hum Reprod; 2005 May 01; 20(5):1207-12. PubMed ID: 15665022
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.
    Kjøtrød SB, von Düring V, Carlsen SM.
    Hum Reprod; 2004 Jun 01; 19(6):1315-22. PubMed ID: 15117902
    [Abstract] [Full Text] [Related]

  • 18. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct 01; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 19. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
    Carlsen SM, Vanky E.
    Hum Reprod; 2010 Mar 01; 25(3):786-90. PubMed ID: 20023292
    [Abstract] [Full Text] [Related]

  • 20. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.